30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Northfield Laboratories Inc (NFLDQ)

Track

Stock chart
Ticker: NFLDQ Exchange: PKL
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
GOULD STEVEN A MD
Chairman/CEO
1 sale — total 369 USD
Sale 5 Jun 2009
Value US$2,420,167.79 | Price 199.53 | Shares 84,292
Sale 4 Jun 2009
Value US$2,826,854.99 | Price 48.94 | Shares 44,400
Sale 4 Jun 2009
Value US$2,397,997.95 | Price 14.74 | Shares 42,227
Sale 3 Jun 2009
Value US$45,717.67 | Price 0.11 | Shares 399,630
Sale 5 Nov 2007
Value US$10,640.00 | Price 1.33 | Shares 8,000
Sale 5 Nov 2007
Value US$2,700.00 | Price 1.35 | Shares 2,000
Sale 23 Oct 2007
Value US$2,385.00 | Price 1.59 | Shares 1,500
Buy 27 Dec 2006
Value US$276,676.54 | Price 3.84 | Shares 72,100
Buy 27 Dec 2006
Value US$276,676.54 | Price 3.84 | Shares 72,100
Sale 15 Dec 2006
Value US$4,383,280.00 | Price 14.96 | Shares 293,000
Sale 15 Dec 2006
Value US$4,383,280.00 | Price 14.96 | Shares 293,000
Buy 15 Dec 2006
Value US$1,612,500.00 | Price 15.00 | Shares 107,500
Buy 15 Dec 2006
Value US$1,612,500.00 | Price 15.00 | Shares 107,500
Sale 11 May 2005
Value US$72,150.00 | Price 14.43 | Shares 5,000
Sale 6 May 2005
Value US$11,160.00 | Price 14.88 | Shares 750
Sale 6 May 2005
Value US$73,350.00 | Price 14.67 | Shares 5,000
Sale 3 Jun 2004
Value US$13,376.00 | Price 12.16 | Shares 1,100
Sale 3 Jun 2004
Value US$14,968.80 | Price 12.15 | Shares 1,232
Sale 3 Jun 2004
Value US$1,205.00 | Price 12.05 | Shares 100
Sale 3 Jun 2004
Value US$6,764.88 | Price 11.91 | Shares 568
Sale 3 Jun 2004
Value US$11,900.00 | Price 11.90 | Shares 1,000
Sale 3 Jun 2004
Value US$546.94 | Price 11.89 | Shares 46
Sale 3 Jun 2004
Value US$11,323.98 | Price 11.87 | Shares 954
Sale 3 Jun 2004
Value US$11,850.00 | Price 11.85 | Shares 1,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2009-06-05 2009-06-05 S Sale GOULD STEVEN A MD

Chairman/CEO

Executive Director
84,292 +35.5%
199.53
US$2,420,168 		84,292 +35.5% 199.53 US$2,420,168
2009-06-05 2009-06-04 S Sale GOULD STEVEN A MD

Chairman/CEO

Executive Director
44,400 -47.5%
48.94
US$2,826,855 		44,400 -47.5% 48.94 US$2,826,855
2009-06-05 2009-06-04 S Sale GOULD STEVEN A MD

Chairman/CEO

Executive Director
42,227 +26.6%
14.74
US$2,397,998 		42,227 +26.6% 14.74 US$2,397,998
2009-06-05 2009-06-03 S Sale GOULD STEVEN A MD

Chairman/CEO

Executive Director
399,630 -73.2%
0.11
US$45,718 		399,630 -73.2% 0.11 US$45,718
2007-11-05 2007-11-05 S Sale KOGUT JACK

Sr. Vice President

Officer
8,000 -9.4%
1.33
US$10,640 		8,000 -9.4% 1.33 US$10,640
2007-11-05 2007-11-05 S Sale KOGUT JACK

Sr. Vice President

Officer
2,000 -2.3%
1.35
US$2,700 		2,000 -2.3% 1.35 US$2,700
2007-10-24 2007-10-23 S Sale MCGINNIS ROBERT

Sr. Vice President

Officer
1,500 -100.0%
1.59
US$2,385 		1,500 -100.0% 1.59 US$2,385
2007-01-24 2006-12-27 B Purchase BALYASNY ASSET MANAGEMENT LLC

Group Member

Large shareholder
72,100 +2.7%
3.84
US$276,677 		72,100 +2.7% 3.84 US$276,677
2007-01-24 2006-12-27 B Purchase Visium Long Bias Offshore Fund, Ltd. Large shareholder
72,100 +2.7%
3.84
US$276,677 		72,100 +2.7% 3.84 US$276,677
2006-12-28 2006-12-15 S Sale BALYASNY ASSET MANAGEMENT LLC

Group Member

Large shareholder
293,000 -99.3%
14.96
US$4,383,280 		293,000 -99.3% 14.96 US$4,383,280
2006-12-28 2006-12-15 S Sale BALYASNY ASSET MANAGEMENT LLC Large shareholder
293,000 -99.3%
14.96
US$4,383,280 		293,000 -99.3% 14.96 US$4,383,280
2006-12-28 2006-12-15 B Purchase BALYASNY ASSET MANAGEMENT LLC

Group Member

Large shareholder
107,500 +102.1%
15.00
US$1,612,500 		107,500 +102.1% 15.00 US$1,612,500
2006-12-28 2006-12-15 B Purchase BALYASNY ASSET MANAGEMENT LLC Large shareholder
107,500 +102.1%
15.00
US$1,612,500 		107,500 +102.1% 15.00 US$1,612,500
2005-05-13 2005-05-11 S Sale OLSHANSKY JACK Non-Executive Director
5,000 -33.4%
14.43
US$72,150 		5,000 -33.4% 14.43 US$72,150
2005-05-10 2005-05-06 S Sale TWADDELL SOPHIA H

Vice President

Officer
750 -21.4%
14.88
US$11,160 		750 -21.4% 14.88 US$11,160
2005-05-10 2005-05-06 S Sale OLSHANSKY JACK Non-Executive Director
5,000 -42.8%
14.67
US$73,350 		5,000 -42.8% 14.67 US$73,350
2004-06-03 2004-06-03 S Sale DOUBLEDAY MARC

Vice President

Officer
1,100 -30.6%
12.16
US$13,376 		1,100 -30.6% 12.16 US$13,376
2004-06-03 2004-06-03 S Sale DOUBLEDAY MARC

Vice President

Officer
1,232 -25.5%
12.15
US$14,969 		1,232 -25.5% 12.15 US$14,969
2004-06-03 2004-06-03 S Sale DOUBLEDAY MARC

Vice President

Officer
100 -2.0%
12.05
US$1,205 		100 -2.0% 12.05 US$1,205
2004-06-03 2004-06-03 S Sale DOUBLEDAY MARC

Vice President

Officer
568 -10.3%
11.91
US$6,765 		568 -10.3% 11.91 US$6,765
2004-06-03 2004-06-03 S Sale DOUBLEDAY MARC

Vice President

Officer
1,000 -15.4%
11.90
US$11,900 		1,000 -15.4% 11.90 US$11,900
2004-06-03 2004-06-03 S Sale DOUBLEDAY MARC

Vice President

Officer
46 -0.7%
11.89
US$547 		46 -0.7% 11.89 US$547
2004-06-03 2004-06-03 S Sale DOUBLEDAY MARC

Vice President

Officer
954 -12.7%
11.87
US$11,324 		954 -12.7% 11.87 US$11,324
2004-06-03 2004-06-03 S Sale DOUBLEDAY MARC

Vice President

Officer
1,000 -11.8%
11.85
US$11,850 		1,000 -11.8% 11.85 US$11,850
Explore more

More insider trading research around Northfield Laboratories Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America